InsiderTrades.com logo
Say Goodbye to the US Dollar
From Sasco Gold LLC   |   Ad
The warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." I believe the American people deserve to control the fate of their own life savings which is why I had my team put together our latest guide to protect your hard-earned wealth before it's too late...
[RUSH MY FREE GUIDE]

BCRX Insider Trading

Insider Ownership Percentage: 4.80%
Insider Buying (Last 12 Months): $596,337.56
Insider Selling (Last 12 Months): $82,486.00

BioCryst Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at BioCryst Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

BioCryst Pharmaceuticals Share Price & Price History

Current Price: $7.98
Price Change: ▼ Price Decrease of -0.15 (-1.85%)
As of 09/6/2024 01:00 AM ET

This chart shows the closing price history over time for BCRX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
The solution to fast food’s wage hike crisis
From Deal Maker   |   Ad
Shake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase, according to the NY Post. With a sky-high 150% turnover rate, the fast food industry is already grappling with labor issues before taking into account these wage hikes. The industry will need a projected 1 million new workers every year through 2032.
Learn more about this much-needed advancement and investment opportunity here.

BioCryst Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/24/2024Amy E MckeeDirectorSell8,600$6.32$54,352.0027,831View SEC Filing Icon  
6/17/2024Machelle SandersDirectorSell4,689$6.00$28,134.0027,742View SEC Filing Icon  
5/30/2024Alan G LevinDirectorBuy7,861$6.36$49,995.9644,951View SEC Filing Icon  
5/24/2024Steve AselageDirectorBuy2,500$6.40$16,000.002,500View SEC Filing Icon  
5/20/2024Nancy J. HutsonDirectorBuy5,000$6.38$31,900.0086,818View SEC Filing Icon  
5/14/2024Anthony DoyleCFOBuy36,300$5.57$202,191.00266,744View SEC Filing Icon  
5/14/2024Helen M ThackrayInsiderBuy30,000$5.86$175,800.00272,139View SEC Filing Icon  
5/13/2024Steven K GalsonDirectorBuy21,940$5.49$120,450.6051,551View SEC Filing Icon  
6/15/2023Machelle SandersDirectorSell4,000$7.98$31,920.0025,611View SEC Filing Icon  
2/1/2023Jon P. StonehouseCEOSell100,000$10.38$1,038,000.001,008,739View SEC Filing Icon  
12/15/2022Anthony DoyleCFOSell5,700$10.90$62,130.00163,966View SEC Filing Icon  
12/15/2022Helen M ThackrayInsiderSell3,125$10.89$34,031.25133,275View SEC Filing Icon  
12/15/2022Jon P. StonehouseCEOSell14,100$10.90$153,690.00887,730View SEC Filing Icon  
12/15/2022Michael L JonesDirectorSell445$10.90$4,850.5010,753View SEC Filing Icon  
12/2/2022Jon P. StonehouseCEOSell82,656$12.80$1,057,996.80901,830View SEC Filing Icon  
12/1/2022Michael L JonesDirectorSell8,600$13.01$111,886.0011,198View SEC Filing Icon  
11/14/2022Yarlagadda S. BabuInsiderSell31,515$13.88$437,428.20298,541View SEC Filing Icon  
4/1/2022Helen M ThackrayInsiderSell7,600$16.20$123,120.00136,400View SEC Filing Icon  
2/15/2022George B. AbercrombieDirectorSell5,000$18.50$92,500.00View SEC Filing Icon  
1/11/2022Jon P. StonehouseCEOSell184,000$15.04$2,767,360.00View SEC Filing Icon  
12/7/2021Yarlagadda S. BabuInsiderSell30,100$12.20$367,220.00View SEC Filing Icon  
11/24/2021Vincent MilanoDirectorBuy7,500$12.19$91,425.00View SEC Filing Icon  
11/23/2021Anthony DoyleCFOBuy35,258$12.48$440,019.84View SEC Filing Icon  
11/15/2021George B. AbercrombieDirectorSell5,000$12.27$61,350.00View SEC Filing Icon  
10/15/2021Nancy J. HutsonDirectorSell105,000$15.40$1,617,000.00View SEC Filing Icon  
9/10/2021George B. AbercrombieDirectorSell74,000$15.09$1,116,660.00View SEC Filing Icon  
See Full Table
“Fed Proof” Your Bank Account with THESE 4 Simple Steps
From Weiss Ratings   |   Ad
Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.
Learn these 4 simple steps and protect your savings before it’s too late.

SEC Filings (Institutional Ownership Changes) for BioCryst Pharmaceuticals (NASDAQ:BCRX)

85.88% of BioCryst Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at BCRX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

BioCryst Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
9/5/2024Sanctuary Advisors LLC26,571$0.16M0.0%N/A0.013%Search for SEC Filing on Google Icon
8/16/2024Northeast Financial Consultants Inc65,633$0.41M0.0%+8.2%0.032%Search for SEC Filing on Google Icon
8/16/2024Creative Planning46,613$0.29M0.0%+75.2%0.023%Search for SEC Filing on Google Icon
8/16/2024Algert Global LLC353,133$2.18M0.1%+18.6%0.171%Search for SEC Filing on Google Icon
8/15/2024Susquehanna Fundamental Investments LLC30,176$0.19M0.0%-53.1%0.015%Search for SEC Filing on Google Icon
8/15/2024Mackenzie Financial Corp27,913$0.17M0.0%-13.5%0.014%Search for SEC Filing on Google Icon
8/15/2024The Manufacturers Life Insurance Company 212,581$1.31M0.0%+113.8%0.103%Search for SEC Filing on Google Icon
8/15/2024Millennium Management LLC1,751,561$10.83M0.0%-13.8%0.849%Search for SEC Filing on Google Icon
8/15/2024Deerfield Management Company L.P. Series C8,135,804$50.28M0.8%+62.9%3.942%Search for SEC Filing on Google Icon
8/15/2024AQR Capital Management LLC543,241$3.36M0.0%+18.8%0.263%Search for SEC Filing on Google Icon
8/15/2024ELCO Management Co. LLC30,792$0.19M0.1%-14.5%0.015%Search for SEC Filing on Google Icon
8/15/2024Point72 Asia Singapore Pte. Ltd.72,666$0.45M0.1%N/A0.035%Search for SEC Filing on Google Icon
8/15/2024Point72 Europe London LLP267,649$1.65M0.1%N/A0.130%Search for SEC Filing on Google Icon
8/14/2024Cubist Systematic Strategies LLC1,112,232$6.87M0.0%+528.0%0.539%Search for SEC Filing on Google Icon
8/14/2024Point72 DIFC Ltd66,564$0.41M0.0%+598.2%0.032%Search for SEC Filing on Google Icon
8/14/2024Xponance Inc.12,980$80K0.0%+13.1%0.006%Search for SEC Filing on Google Icon
8/14/2024Avoro Capital Advisors LLC12,570,000$77.68M1.0%-3.7%6.091%Search for SEC Filing on Google Icon
8/14/2024DRW Securities LLC11,987$74K0.0%N/A0.006%Search for SEC Filing on Google Icon
8/14/2024ProShare Advisors LLC38,128$0.24M0.0%-21.4%0.018%Search for SEC Filing on Google Icon
8/14/2024Profund Advisors LLC86,815$0.54M0.0%-64.1%0.042%Search for SEC Filing on Google Icon
8/12/2024Inspire Investing LLC57,550$0.36M0.0%-17.2%0.028%Search for SEC Filing on Google Icon
8/12/2024XTX Topco Ltd156,946$0.97M0.1%+299.0%0.076%Search for SEC Filing on Google Icon
8/12/2024Seven Eight Capital LP169,612$1.05M0.1%+1,407.1%0.082%Search for SEC Filing on Google Icon
8/12/2024Hsbc Holdings PLC125,004$0.76M0.0%+32.7%0.061%Search for SEC Filing on Google Icon
8/12/2024E Fund Management Co. Ltd.28,285$0.18M0.0%-61.9%0.014%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC960,180$5.93M0.0%-39.6%0.465%Search for SEC Filing on Google Icon
8/8/2024American Century Companies Inc.148,490$0.92M0.0%+896.6%0.072%Search for SEC Filing on Google Icon
8/8/2024Rice Hall James & Associates LLC2,079,641$12.85M0.8%-3.3%1.008%Search for SEC Filing on Google Icon
8/7/2024Headlands Technologies LLC16,750$0.10M0.0%N/A0.008%Search for SEC Filing on Google Icon
8/6/2024Los Angeles Capital Management LLC97,577$0.60M0.0%+8.9%0.047%Search for SEC Filing on Google Icon
8/3/2024TD Asset Management Inc240,600$1.49M0.0%N/A0.117%Search for SEC Filing on Google Icon
8/1/2024Rhumbline Advisers318,665$1.97M0.0%+6.3%0.154%Search for SEC Filing on Google Icon
7/31/2024nVerses Capital LLC10,200$63K0.0%N/A0.005%Search for SEC Filing on Google Icon
7/31/2024Commonwealth Equity Services LLC143,874$0.89M0.0%-1.0%0.070%Search for SEC Filing on Google Icon
7/30/2024Signaturefd LLC6,598$41K0.0%+560.5%0.003%Search for SEC Filing on Google Icon
7/29/2024Principal Financial Group Inc.35,524$0.22M0.0%-26.3%0.017%Search for SEC Filing on Google Icon
7/29/2024Panagora Asset Management Inc.650,318$4.02M0.0%+2.8%0.315%Search for SEC Filing on Google Icon
7/27/2024Leisure Capital Management28,000$0.17M0.1%N/A0.014%Search for SEC Filing on Google Icon
7/26/2024Bank of New York Mellon Corp775,957$4.80M0.0%+12.5%0.376%Search for SEC Filing on Google Icon
7/18/2024Assenagon Asset Management S.A.64,907$0.40M0.0%-83.2%0.031%Search for SEC Filing on Google Icon
7/16/2024Diversified Trust Co24,752$0.15M0.0%+18.0%0.012%Search for SEC Filing on Google Icon
7/10/2024CWM LLC5,658$35K0.0%+200.0%0.003%Search for SEC Filing on Google Icon
5/17/2024Tidal Investments LLC55,560$0.28M0.0%N/A0.027%Search for SEC Filing on Google Icon
5/16/2024Redwood Investment Management LLC122,270$0.62M0.1%N/A0.059%Search for SEC Filing on Google Icon
5/16/2024California State Teachers Retirement System184,788$0.94M0.0%-7.6%0.090%Search for SEC Filing on Google Icon
5/16/2024Jacobs Levy Equity Management Inc.156,119$0.79M0.0%+62.0%0.076%Search for SEC Filing on Google Icon
5/16/2024Kynam Capital Management LP6,527,491$33.16M3.5%+41.9%3.163%Search for SEC Filing on Google Icon
5/15/2024Sarissa Capital Management LP1,094,168$5.56M1.0%+9.4%0.530%Search for SEC Filing on Google Icon
5/15/2024Price T Rowe Associates Inc. MD130,775$0.67M0.0%+15.0%0.063%Search for SEC Filing on Google Icon
5/14/2024Nan Fung Group Holdings Ltd36,847$0.19M0.2%+106.5%0.018%Search for SEC Filing on Google Icon
5/14/2024EntryPoint Capital LLC42,679$0.22M0.2%+689.8%0.021%Search for SEC Filing on Google Icon
5/14/2024Shell Asset Management Co.21,854$0.11M0.0%N/A0.011%Search for SEC Filing on Google Icon
5/14/2024Natixis11,684$59K0.0%+400.6%0.006%Search for SEC Filing on Google Icon
5/13/2024Seven Eight Capital LP11,254$57K0.0%N/A0.005%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.17,676,767$89.80M0.0%-0.5%8.567%Search for SEC Filing on Google Icon
5/8/2024ProShare Advisors LLC48,503$0.25M0.0%+9.1%0.024%Search for SEC Filing on Google Icon
5/8/2024Russell Investments Group Ltd.58,725$0.30M0.0%+200.8%0.028%Search for SEC Filing on Google Icon
5/8/2024Inspire Investing LLC69,466$0.35M0.0%+9.7%0.034%Search for SEC Filing on Google Icon
5/7/2024Susquehanna Fundamental Investments LLC64,365$0.33M0.0%N/A0.031%Search for SEC Filing on Google Icon
5/7/2024Swiss National Bank363,968$1.85M0.0%-2.5%0.176%Search for SEC Filing on Google Icon
5/7/2024SG Americas Securities LLC13,548$69K0.0%-79.5%0.007%Search for SEC Filing on Google Icon
5/2/2024Mutual of America Capital Management LLC212,781$1.08M0.0%-4.0%0.103%Search for SEC Filing on Google Icon
5/1/2024BNP Paribas Financial Markets167,782$0.85M0.0%-78.8%0.081%Search for SEC Filing on Google Icon
5/1/2024Mirae Asset Global Investments Co. Ltd.138,074$0.70M0.0%+13.0%0.067%Search for SEC Filing on Google Icon
4/30/2024J.W. Cole Advisors Inc.12,600$64K0.0%-37.3%0.006%Search for SEC Filing on Google Icon
4/29/2024China Universal Asset Management Co. Ltd.39,639$0.20M0.0%+67.3%0.019%Search for SEC Filing on Google Icon
4/24/2024Assenagon Asset Management S.A.386,885$1.97M0.0%-26.9%0.188%Search for SEC Filing on Google Icon
4/23/2024Rice Hall James & Associates LLC2,151,545$10.93M0.6%-2.1%1.044%Search for SEC Filing on Google Icon
4/5/2024Los Angeles Capital Management LLC89,614$0.46M0.0%+68.0%0.043%Search for SEC Filing on Google Icon
3/11/2024Vanguard Group Inc.17,763,720$106.41M0.0%+15.4%8.617%Search for SEC Filing on Google Icon
3/5/2024Fisher Asset Management LLC2,884,569$17.28M0.0%-9.4%1.399%Search for SEC Filing on Google Icon
2/27/2024Counterweight Ventures LLC13,500$81K0.1%N/A0.007%Search for SEC Filing on Google Icon
2/20/2024Quarry LP9,000$54K0.0%N/A0.004%Search for SEC Filing on Google Icon
2/14/2024Oracle Investment Management Inc.535,558$3.21M2.0%-3.6%0.261%Search for SEC Filing on Google Icon
2/14/2024Braidwell LP5,718,477$34.25M1.3%+6.6%2.792%Search for SEC Filing on Google Icon
2/14/2024Avoro Capital Advisors LLC13,050,000$78.17M1.1%+13.0%6.372%Search for SEC Filing on Google Icon
2/14/2024Kynam Capital Management LP4,600,000$27.55M3.1%+46.8%2.246%Search for SEC Filing on Google Icon
2/13/2024Tower Research Capital LLC TRC10,420$62K0.0%+131.1%0.005%Search for SEC Filing on Google Icon
2/13/2024Rafferty Asset Management LLC955,587$5.72M0.0%+18.3%0.467%Search for SEC Filing on Google Icon
2/12/2024Capstone Investment Advisors LLC18,650$0.11M0.0%N/A0.009%Search for SEC Filing on Google Icon
2/9/2024Aigen Investment Management LP12,670$76K0.0%-91.7%0.006%Search for SEC Filing on Google Icon
2/9/2024GW&K Investment Management LLC2,337,683$14M0.1%-9.1%1.141%Search for SEC Filing on Google Icon
2/9/2024Trexquant Investment LP421,516$2.53M0.1%-28.9%0.206%Search for SEC Filing on Google Icon
2/9/2024Norges Bank2,216,612$13.28M0.0%N/A1.082%Search for SEC Filing on Google Icon
2/8/2024Panagora Asset Management Inc.669,067$4.01M0.0%-8.0%0.327%Search for SEC Filing on Google Icon
2/8/2024Pinnacle Wealth Planning Services Inc.20,561$0.12M0.0%N/A0.010%Search for SEC Filing on Google Icon
2/7/2024Jump Financial LLC128,771$0.77M0.0%-68.2%0.063%Search for SEC Filing on Google Icon
2/7/2024BNP Paribas Financial Markets790,163$4.73M0.0%+45.5%0.386%Search for SEC Filing on Google Icon
2/7/2024Teacher Retirement System of Texas43,827$0.26M0.0%-18.3%0.021%Search for SEC Filing on Google Icon
2/7/2024E Fund Management Co. Ltd.51,317$0.31M0.0%+23.7%0.025%Search for SEC Filing on Google Icon
2/6/2024Charles Schwab Investment Management Inc.1,594,436$9.55M0.0%+9.1%0.778%Search for SEC Filing on Google Icon
2/6/2024Amalgamated Bank24,257$0.15M0.0%-7.2%0.012%Search for SEC Filing on Google Icon
2/6/2024Los Angeles Capital Management LLC53,330$0.32M0.0%+61.0%0.026%Search for SEC Filing on Google Icon
2/6/2024Swiss National Bank373,468$2.24M0.0%-10.1%0.182%Search for SEC Filing on Google Icon
2/6/2024Fisher Asset Management LLC2,884,097$17.28M0.0%-9.5%1.408%Search for SEC Filing on Google Icon
2/5/2024Victory Capital Management Inc.26,842$0.16M0.0%+31.5%0.013%Search for SEC Filing on Google Icon
2/1/2024New York State Common Retirement Fund59,075$0.35M0.0%-23.2%0.029%Search for SEC Filing on Google Icon
2/1/2024Handelsbanken Fonder AB45,900$0.28M0.0%+29.3%0.022%Search for SEC Filing on Google Icon
1/31/2024abrdn plc504,528$3.02M0.0%N/A0.246%Search for SEC Filing on Google Icon
1/30/2024Zurcher Kantonalbank Zurich Cantonalbank47,359$0.28M0.0%+27.1%0.023%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
BioCryst Pharmaceuticals logo
BioCryst Pharmaceuticals, Inc., a biotechnology company, develops oral small-molecule and protein therapeutics to treat rare diseases. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX10013, an oral factor D inhibitor for complement-mediated diseases. The company has collaborations and in-license relationships with the Torii Pharmaceutical Co., Ltd.; Seqirus UK Limited; Shionogi & Co., Ltd.; Green Cross Corporation; National Institute of Allergy and Infectious Diseases; Biomedical Advanced Research and Development Authority; the U.S. Department of Health and Human Services; and The University of Alabama at Birmingham, as well as Albert Einstein College of Medicine of Yeshiva University and Industrial Research, Ltd. BioCryst Pharmaceuticals, Inc. was founded in 1986 and is headquartered in Durham, North Carolina.
Read More on BioCryst Pharmaceuticals

Today's Range

Now: $7.98
Low: $7.91
High: $8.25

50 Day Range

MA: $7.54
Low: $6.41
High: $8.69

52 Week Range

Now: $7.98
Low: $4.03
High: $8.88

Volume

1,287,010 shs

Average Volume

3,226,499 shs

Market Capitalization

$1.65 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.88

Who are the company insiders with the largest holdings of BioCryst Pharmaceuticals?

BioCryst Pharmaceuticals' top insider shareholders include:
  1. Jon P Stonehouse (CEO)
  2. Yarlagadda S Babu (Insider)
  3. Helen M Thackray (Insider)
  4. Anthony Doyle (CFO)
  5. Nancy J Hutson (Director)
  6. Steven K Galson (Director)
  7. Alan G Levin (Director)
  8. Amy E Mckee (Director)
  9. Machelle Sanders (Director)
  10. Michael L Jones (Director)
  11. Steve Aselage (Director)
Learn More about top insider investors at BioCryst Pharmaceuticals.

Who are the major institutional investors of BioCryst Pharmaceuticals?

BioCryst Pharmaceuticals' top institutional shareholders include:
  1. Avoro Capital Advisors LLC — 6.09%
  2. Deerfield Management Company L.P. Series C — 3.94%
  3. Rice Hall James & Associates LLC — 1.01%
  4. Millennium Management LLC — 0.85%
  5. Cubist Systematic Strategies LLC — 0.54%
  6. Renaissance Technologies LLC — 0.47%
Learn More about top institutional investors of BioCryst Pharmaceuticals stock.

Which major investors are selling BioCryst Pharmaceuticals stock?

During the last quarter, BCRX stock was sold by these institutional investors:
  1. Renaissance Technologies LLC
  2. Avoro Capital Advisors LLC
  3. Assenagon Asset Management S.A.
  4. Millennium Management LLC
  5. Profund Advisors LLC
  6. Rice Hall James & Associates LLC
  7. E Fund Management Co. Ltd.
  8. Susquehanna Fundamental Investments LLC
Within the previous year, company insiders that have sold BioCryst Pharmaceuticals company stock include:
  1. Jon P Stonehouse (CEO)
  2. Yarlagadda S Babu (Insider)
Learn More investors selling BioCryst Pharmaceuticals stock.

Which major investors are buying BioCryst Pharmaceuticals stock?

Within the previous quarter, BCRX stock was bought by institutional investors including:
  1. Deerfield Management Company L.P. Series C
  2. Cubist Systematic Strategies LLC
  3. Point72 Europe London LLP
  4. TD Asset Management Inc
  5. Seven Eight Capital LP
  6. American Century Companies Inc.
  7. XTX Topco Ltd
  8. The Manufacturers Life Insurance Company
In the previous year, these company insiders have bought BioCryst Pharmaceuticals stock:
  1. Jon P Stonehouse (CEO)
  2. Yarlagadda S Babu (Insider)
  3. Helen M Thackray (Insider)
  4. Anthony Doyle (CFO)
  5. Nancy J Hutson (Director)
  6. Steven K Galson (Director)
Learn More investors buying BioCryst Pharmaceuticals stock.
Say Goodbye to the US Dollar
From Sasco Gold LLC   |   Ad
The warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." I believe the American people deserve to control the fate of their own life savings which is why I had my team put together our latest guide to protect your hard-earned wealth before it's too late...
[RUSH MY FREE GUIDE]